A Phase 1 Safety and Pharmacokinetic Study of ABT-263 in Combination with Paclitaxel in the Treatment of Subjects with Solid Tumors.
Safety study of ABT-263 in Combination with Paclitaxel in Subjects with Solid Tumors.